Mehmet Sabanci
Research Subjects
Research Interests
Mehmet Sabanci has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Burcu Öksüz
Molecular Infection Laboratory, Genetic Diseases Diagnosis Center, İstinye University, Istanbul, Turkey
1 shared publication - Mehmet Taşdemir
Department of Pediatric Nephrology, Faculty of Medicine, Istinye University, Istanbul 34475, Türkiye
1 shared publication - Murat Sütçü
Department of Pediatric Infectious Diseases, Faculty of Medicine, Istinye University, Istanbul, Turkey
1 shared publication - Ozan Özkaya
Liv Bahçeşehir Hospital, Department of Pediatric Nephrology, İstinye University, İstanbul, Turkey
1 shared publication - Yasemin Altuner Torun
Division of Pediatric Hematology, Department of Pediatrics, İstinye University School of Medicine, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 22 May 2024
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (10) , 2923-2925
Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant
A 13-year-old girl who had a kidney transplant four weeks prior presented with a 10-day history of fatigue, paleness, and headache. On physical examination, tachycardia and paleness were noted. Laboratory testing was notable for severe anemia and mild leukopenia and thrombocytopenia. Polymerase chain reaction (PCR) test for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were negative and for parvovirus B19 (PVB19) was positive. Despite lower immunosuppression and administration of intravenous immunoglobulin (IVIG) it persisted for 15 months, and frequent red blood cell transfusions were needed. PVB19 is a less common but significant complication. The patient's clinical course demonstrates the importance of this complication and the challenges in its management. A notable void exists in the literature regarding standardized treatment protocols for PVB19-induced recurrent anemia after kidney transplant. This case indicates the need for further research and consensus to guide effective clinical interventions in similar cases.
- 22 May 2024
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (10) , 2923-2925
Open AccessManaging recurrent parvovirus B19-associated anemia after a pediatric kidney transplant
A 13-year-old girl who had a kidney transplant four weeks prior presented with a 10-day history of fatigue, paleness, and headache. On physical examination, tachycardia and paleness were noted. Laboratory testing was notable for severe anemia and mild leukopenia and thrombocytopenia. Polymerase chain reaction (PCR) test for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were negative and for parvovirus B19 (PVB19) was positive. Despite lower immunosuppression and administration of intravenous immunoglobulin (IVIG) it persisted for 15 months, and frequent red blood cell transfusions were needed. PVB19 is a less common but significant complication. The patient's clinical course demonstrates the importance of this complication and the challenges in its management. A notable void exists in the literature regarding standardized treatment protocols for PVB19-induced recurrent anemia after kidney transplant. This case indicates the need for further research and consensus to guide effective clinical interventions in similar cases.